ID | Name | Number of studies | |
---|---|---|---|
CL_0000561 | amacrine cell | 10 | |
CL_4030027 | GABAergic amacrine cell | 4 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
---|---|---|---|---|---|
CPLX3 | 3 | 45% ± 14% | 0 | 1 | |
DACH2 | 3 | 28% ± 6% | 0 | 4 | |
CDH7 | 3 | 24% ± 2% | 0 | 6 | |
GLRA2 | 3 | 27% ± 4% | 0 | 7 | |
OLFM3 | 3 | 47% ± 4% | 0 | 8 | |
ZMAT4 | 3 | 37% ± 5% | 0 | 8 | |
KCNB2 | 3 | 48% ± 15% | 0 | 9 | |
FSTL4 | 3 | 42% ± 6% | 0 | 9 | |
SNCB | 3 | 61% ± 16% | 0 | 12 | |
UNC13C | 3 | 51% ± 13% | 0 | 12 | |
RAB3A | 3 | 53% ± 24% | 0 | 13 | |
TFAP2B | 4 | 52% ± 6% | 1 | 4 | |
GAD1 | 4 | 51% ± 15% | 1 | 5 | |
SYNPR | 4 | 58% ± 21% | 1 | 8 | |
NSG2 | 4 | 43% ± 14% | 1 | 10 | |
C1QL2 | 3 | 25% ± 7% | 1 | 2 | |
HUNK | 3 | 31% ± 5% | 1 | 5 | |
KLHL1 | 3 | 38% ± 7% | 1 | 5 | |
TMEFF1 | 3 | 24% ± 6% | 1 | 6 | |
GAD2 | 3 | 44% ± 7% | 1 | 7 | |
GNG3 | 3 | 38% ± 14% | 1 | 7 | |
KCNH5 | 3 | 41% ± 15% | 1 | 8 | |
PLPPR1 | 3 | 68% ± 11% | 1 | 8 | |
KCNC2 | 3 | 55% ± 7% | 1 | 8 | |
NEXMIF | 3 | 23% ± 3% | 1 | 8 | |
MGARP | 3 | 47% ± 14% | 1 | 9 | |
CALY | 3 | 31% ± 11% | 1 | 9 | |
PAK5 | 3 | 34% ± 9% | 1 | 9 | |
CRABP1 | 4 | 27% ± 13% | 2 | 8 | |
ELAVL3 | 4 | 31% ± 16% | 2 | 13 |
GO_0097070 | Biological process | ductus arteriosus closure |
GO_0061002 | Biological process | negative regulation of dendritic spine morphogenesis |
GO_0072017 | Biological process | distal tubule development |
GO_0072044 | Biological process | collecting duct development |
GO_0035136 | Biological process | forelimb morphogenesis |
GO_0035137 | Biological process | hindlimb morphogenesis |
Cell type name | GABAergic amacrine cell |
Synonyms | amacrine cell GABAergic |
Description | An amacrine cell that uses GABA as a neurotransmitter. |
Parent | CL_0000561 |